bibliographicCitation |
Kjeldsen SE, Narkiewicz K, Burnier M, Oparil S. Need for multiple risk reduction strategies in clinical trials enrolling high risk patients - FOURIER investigating PCSK-9 inhibitor to lower cholesterol revisited. Blood Press. 2019 Jun;28(3):144–5. doi: 10.1080/08037051.2019.1614278. PMID: 31076016. |